Neurorobiology and evidence-based biological treatments for substance abuse disorders.
Behavioral patterns of addiction include compulsive drug-seeking, persistent abuse of substances despite the often dire consequences on social functioning and physical health, and the high probability of relapse even after prolonged drug-free periods. The recent focus on the biological basis of addiction has provided evidence to support the hypothesis that behavioral manifestations for addiction are influenced by biological factors, and biological factors often produce behavioral changes that can further increase risk. The current understanding of the role of the dopaminergic, glutamatergic, Upsilon-aminobutyric acidergic, and opioid receptor systems in the pathophysiology of addiction as well as the clinical implications of these systems for new and emerging treatments will be discussed. This article will also review the pharmacologic agents used in the treatment of substance abuse disorders and presents evidence-based data for their safety, efficacy, and feasibility of use in different patient populations.
Ivanov
Iliyan S
IS
Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029, USA. iliyan.ivanov@mssm.edu
Schulz
Kurt P
KP
Palmero
Robyn C
RC
Newcorn
Jeffrey H
JH
D001921:Brain / Q000503:physiopathology; D019317:Evidence-Based Medicine; D005240:Feasibility Studies; D006801:Humans; D011619:Psychotropic Drugs / Q000627:therapeutic use; D011954:Receptors, Dopamine / Q000502:physiology; D018079:Receptors, GABA / Q000502:physiology; D017470:Receptors, Glutamate / Q000502:physiology; D011957:Receptors, Opioid / Q000502:physiology; D019966:Substance-Related Disorders / Q000503:physiopathology / Q000523:psychology / Q000534:rehabilitation*; D016896:Treatment Outcome
D011619:Psychotropic Drugs; D011954:Receptors, Dopamine; D018079:Receptors, GABA; D017470:Receptors, Glutamate; D011957:Receptors, Opioid